mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.5 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.074 |
0.04 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.1 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |